Search

everythinglearnresearchcommunity

for

Search:↓

New nanofiber technology improves wound healing by supporting cell growth and delivering treatments directly to the wound.

Understanding different types of skin cells, especially fibroblasts, can lead to better treatments for wound healing and less scarring.

Nanoparticles can improve skin treatments by better targeting hair follicles, but more research is needed for advancement.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Nanoparticle systems make cancer treatment less toxic.

Improved Finasteride delivery for hair loss treatment.

Human placenta hydrogel helps restore cells needed for hair growth.

Nanotechnology could make hair loss treatments more effective and reduce side effects, but more research is needed before it's available.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Hair follicle culture helps develop new treatments for hair loss.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The document warns against US clinics selling untested stem cell treatments without FDA approval.

Active transdermal technologies in cosmetics help deliver skin treatments effectively, but their safety and effectiveness depend on skin type and treatment choice.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

New hair can grow from large wounds in mice, but less so as they age, involving reprogramming of skin cells and specific molecular pathways.

Dermoscopy is useful for many health professionals, not just dermatologists, in improving skin condition diagnoses and reducing unnecessary biopsies.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Hair follicle regeneration and delivery is complex due to many molecular and cellular factors.

Accurate quantitative bioanalysis using LC-MS/MS is challenging due to matrix effects, but using internal standards and new methods like in-sample calibration could improve results.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

HASHA is a safe and effective option for chin augmentation.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.